STAT1 and neoplasm: It can also reduce the accumulation of CD8+ T cells in tumor tissues through the interferon (IFN)‐γ‐mediated activation of the JAK1‐STAT1‐IRF1 pathway, thereby mediating tumor immunosuppression in breast cancer [19].